[2][3] After UK legalisation of medical cannabis in November 2018,[4] Releaf Dispensary Ltd, founded by Mason Soiza,[5] was incorporated on 10 May 2022.

[6] Buoyed by a £1.5m funding round in 2023,[1] Releaf developed a health technology platform to ease access to cannabis-based prescription medicines (CBPMs) for patients.

[5][7] Releaf has conducted surveys[7] and organised campaigns to inform medical professionals[8] and to promote broader awareness among potential patients about the CBPMs space including through celebrity users,[9][10] promotion of CBPM ID cards,[2][3] and information about how CBPMs might be consumed.

[11] Releaf is a member of the UK's Cannabis Industry Council.

[12] Chloe Durrington was the first patient in the UK to be prescribed by Releaf with cannabis flower,[13] which was grown legally for commercial sale by Glass Pharms.